1. From Amgen Inc (M.M.V.), Thousand Oaks, Calif; the Gladstone Institute of Cardiovascular Disease (S.W., S.G.Y.), University of California, San Francisco; the Cardiovascular Research Institute (S.G.Y.), University of California, San Francisco; and the Department of Medicine (S.G.Y.), University of California, San Francisco, and the Medical Service (S.G.Y.), San Francisco General Hospital, San Francisco, Calif.